A Phase 2 Trial Of Nivolumab And Temozolomide In Extensive Stage Small Cell Lung Cancer: Interim Efficacy Analysis.

JOURNAL OF THORACIC ONCOLOGY(2021)

引用 0|浏览6
暂无评分
关键词
small cell lung cancer, Immunotherapy, Immune checkpoint inhibitor
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要